Epidermal stem cells participate in the repair of scalds via Nanog and Myc regulation

Yin,Delong; Zhang,Xiaohui; Jiang,Qinying; Luo,Shuai; Luo,Yang; Cheng,Peng; Jin,Guoqing; Liu,Changyu

doi:10.3892/mmr.2022.12881

Epidermal stem cells participate in the repair of scalds via Nanog and Myc regulation

Authors:
- Delong Yin
- Xiaohui Zhang
- Qinying Jiang
- Shuai Luo
- Yang Luo
- Peng Cheng
- Guoqing Jin
- Changyu Liu
View Affiliations

Affiliations: Department of Orthopedics, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China, Department of Orthopedics, The Third Clinical School of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China, Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Intensive Care Unit, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China
Published online on: October 24, 2022 https://doi.org/10.3892/mmr.2022.12881
Article Number: 364
Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Epidermal stem cells (EpSCs) with high expression of regulatory factor Nanog can promote wound healing. The aim of the present study was to investigate the effectiveness and mechanism of epidermal stem cells (EpSCs) in healing scalds and the underlying molecular mechanism. Mouse EpSCs were isolated from skin tissues and cultured in vitro. First, the proliferative ability of EpSCs was determined via the upregulation and downregulation of Nanog expression levels in EpSCs using the MTS‑assay. Second, a wound healing assay of the EpSCs with different Nanog expression levels was performed to investigate cell migratory capacities. Third, the protein expression levels of various proteins in EpSCs with Nanog overexpression or knockdown, were determined. Finally, the transfected EpSCs were applied to the rat scald model to observe their effect on scald healing. Subsequently, wound scores, re‑epithelialization and capillary density were determined histologically. The results demonstrated that Nanog overexpression enhanced the proliferative ability of EpSCs via cellular (c)‑Myc. Moreover, the LV‑Nanog group of EpSCs with increased Nanog expression levels exhibited improved healing abilities in the wound healing test than control group. Using western blotting, it was demonstrated that EpSCs that were transfected with a Nanog‑overexpression vector expressed high Nanog protein expression levels, whereas small interfering RNA‑Nanog‑transfected EpSCs exhibited low Nanog protein expression levels. Furthermore, c‑Myc expression was synchronized with Nanog expression. It was also revealed that as the expression levels of c‑Myc increased, p53 expression levels also increased. In the rat scald model, Nanog‑overexpressing EpSCs enhanced wound closure and re‑epithelialization. The EpSCs with Nanog knockdown exhibited the opposite effects. The present study therefore indicated that Nanog may have a positive effect on scald healing in rats, which supports its use in EpSC‑based treatments against scalds. Furthermore, it was suggested that c‑Myc potentially serves a key role in this process and that this process avoids cancerization by relying on the supervision of p53.

View Figures

View References

1	Wei X, Yang X, Han ZP, Qu FF, Shao L and Shi YF: Mesenchymal stem cells: A new trend for cell therapy. Acta Pharmacol Sin. 34:747–754. 2013. View Article : Google Scholar : PubMed/NCBI
2	Jeschke MG, Rehou S, McCann MR and Shahrokhi S: Allogeneic mesenchymal stem cells for treatment of severe burn injury. Stem Cell Res Ther. 10:3372019. View Article : Google Scholar : PubMed/NCBI
3	Kosaric N, Kiwanuka H and Gurtner GC: Stem cell therapies for wound healing. Expert Opin Biol Ther. 19:575–585. 2019. View Article : Google Scholar : PubMed/NCBI
4	Yang R, Liu F, Wang J, Chen X, Xie J and Xiong K: Epidermal stem cells in wound healing and their clinical applications. Stem Cell Res Ther. 10:2292019. View Article : Google Scholar : PubMed/NCBI
5	Morasso MI and Tomic-Canic M: Epidermal stem cells: The cradle of epidermal determination, differentiation and wound healing. Biol Cell. 97:173–183. 2005. View Article : Google Scholar : PubMed/NCBI
6	Li Y, Zhang J, Yue J, Gou X and Wu X: Epidermal stem cells in skin wound healing. Adv Wound Care (New Rochelle). 6:297–307. 2017. View Article : Google Scholar : PubMed/NCBI
7	Brockmann I, Ehrenpfordt J, Sturmheit T, Brandenburger M, Kruse C, Zille M, Rose D and Boltze J: Skin-derived stem cells for wound treatment using cultured epidermal autografts: Clinical applications and challenges. Stem Cells Int. 2018:46236152018. View Article : Google Scholar : PubMed/NCBI
8	Teng M, Huang Y and Zhang H: Application of stems cells in wound healing-an update. Wound Repair Regen. 22:151–160. 2014. View Article : Google Scholar : PubMed/NCBI
9	Dash BC, Xu Z, Lin L, Koo A, Ndon S, Berthiaume F, Dardik A and Hsia H: Stem cells and engineered scaffolds for regenerative wound healing. Bioengineering (Basel). 5:232018. View Article : Google Scholar : PubMed/NCBI
10	Silva J, Chambers I, Pollard S and Smith A: Nanog promotes transfer of pluripotency after cell fusion. Nature. 441:997–1001. 2006. View Article : Google Scholar : PubMed/NCBI
11	Hayashi Y, Caboni L, Das D, Yumoto F, Clayton T, Deller MC, Nguyen P, Farr CL, Chiu HJ, Miller MD, et al: Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Proc Natl Acad Sci USA. 112:4666–4671. 2015. View Article : Google Scholar : PubMed/NCBI
12	Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
13	Pashaiasl M, Khodadadi K, Kayvanjoo AH, Pashaei-Asl R, Ebrahimie E and Ebrahimi M: Unravelling evolution of Nanog, the key transcription factor involved in self-renewal of undifferentiated embryonic stem cells, by pattern recognition in nucleotide and tandem repeats characteristics. Gene. 578:194–204. 2016. View Article : Google Scholar : PubMed/NCBI
14	Yin D, Tian L, Ye Y, Li K, Wang J, Cheng P, Chen A, Guo F and Huang H: Nanog and β-catenin: A new convergence point in EpSC proliferation and differentiation. Int J Mol Med. 29:587–592. 2012. View Article : Google Scholar : PubMed/NCBI
15	Cheng P, Sun X, Yin D, Xu F, Yang K, Qin L, Dong Y, Guo F, Chen A, Zhang W and Huang H: Nanog down-regulates the Wnt signaling pathway via β-catenin phosphorylation during epidermal stem cell proliferation and differentiation. Cell Biosci. 5:52015. View Article : Google Scholar : PubMed/NCBI
16	National Research Council, . Guide for the care and use of laboratory animals. 8th edition. The National Academies Press; Washington, DC: pp. 2462011
17	Liu Y, Zhou H and Gao F: Isolation and identification of stem cells from adult cashmere goat skin. Int J Dermatol. 47:551–556. 2008. View Article : Google Scholar : PubMed/NCBI
18	Jensen KB, Driskell RR and Watt FM: Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat Protoc. 5:898–911. 2010. View Article : Google Scholar : PubMed/NCBI
19	Wong D, Makowska IJ and Weary DM: Rat aversion to isoflurane versus carbon dioxide. Biol Lett. 9:201210002012. View Article : Google Scholar : PubMed/NCBI
20	Hickman DL and Johnson SW: Evaluation of the aesthetics of physical methods of euthanasia of anesthetized rats. J Am Assoc Lab Anim Sci. 50:695–701. 2011.PubMed/NCBI
21	Dang CV: MYC on the path to cancer. Cell. 149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
22	Gabay M, Li Y and Felsher DW: MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 4:a0142412014. View Article : Google Scholar : PubMed/NCBI
23	Li L, Gu W, Du J, Reid B, Deng X, Liu Z, Zong Z, Wang H, Yao B, Yang C, et al: Electric fields guide migration of epidermal stem cells and promote skin wound healing. Wound Repair Regen. 20:840–851. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yang R, Wang J, Chen X, Shi Y and Xie J: Epidermal stem cells in wound healing and regeneration. Stem Cells Int. 2020:91483102020. View Article : Google Scholar : PubMed/NCBI
25	Finley LWS, Vardhana SA, Carey BW, Alonso-Curbelo D, Koche R, Chen Y, Wen D, King B, Radler MR, Rafii S, et al: Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. Nat Cell Biol. 20:565–574. 2018. View Article : Google Scholar : PubMed/NCBI
26	Pan G and Thomson JA: Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 17:42–49. 2007. View Article : Google Scholar : PubMed/NCBI
27	Bijonowski BM, Yuan X, Jeske R, Li Y and Grant SC: Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells. Sci Rep. 10:204482020. View Article : Google Scholar : PubMed/NCBI
28	Kim J, Chu J, Shen X, Wang J and Orkin SH: An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 132:1049–1061. 2008. View Article : Google Scholar : PubMed/NCBI
29	Cartwright P, McLean C, Sheppard A, Rivett D, Jones K and Dalton S: LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development. 132:885–896. 2005. View Article : Google Scholar : PubMed/NCBI
30	Wernig M, Meissner A, Cassady JP and Jaenisch R: c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell. 2:10–12. 2008. View Article : Google Scholar : PubMed/NCBI
31	Fagnocchi L, Cherubini A, Hatsuda H, Fasciani A, Mazzoleni S, Poli V, Berno V, Rossi RL, Reinbold R, Endele M, et al: A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity. Nat Commun. 7:119032016. View Article : Google Scholar : PubMed/NCBI
32	Carroll PA, Freie BW, Mathsyaraja H and Eisenman RN: The MYC transcription factor network: Balancing metabolism, proliferation and oncogenesis. Front Med. 12:412–425. 2018. View Article : Google Scholar : PubMed/NCBI
33	Maoz M, Devir M, Inbar M, Inbar-Daniel Z, Sherill-Rofe D, Bloch I, Meir K, Edelman D, Azzam S, Nechushtan H, et al: Clinical implications of sub-grouping HER2 positive tumors by amplicon structure and co-amplified genes. Sci Rep. 9:187952019. View Article : Google Scholar : PubMed/NCBI
34	Spencer CA and Groudine M: Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res. 56:1–48. 1991. View Article : Google Scholar : PubMed/NCBI
35	Eilers M, Schirm S and Bishop JM: The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133–141. 1991. View Article : Google Scholar : PubMed/NCBI
36	Yoon K, Lim YS, Yu SB, Kim DS, Ryu SJ, Kim KH, Jang TH and Kim SH: The expression of survivin and its related genes in adipocyte-derived stem cell by demethylation. Korean J Anesthesiol. 58:383–390. 2010. View Article : Google Scholar : PubMed/NCBI
37	Levens D: You don't muck with MYC. Genes Cancer. 1:547–554. 2010. View Article : Google Scholar : PubMed/NCBI
38	Farrell AS and Sears RC: MYC degradation. Cold Spring Harb Perspect Med. 4:a0143652014. View Article : Google Scholar : PubMed/NCBI
39	Swaidan NT, Salloum-Asfar S, Palangi F, Errafii K, Soliman NH, Aboughalia AT, Wali AHS, Abdulla SA and Emara MM: Identification of potential transcription factors that enhance human iPSC generation. Sci Rep. 10:219502020. View Article : Google Scholar : PubMed/NCBI
40	Pitolli C, Wang Y, Candi E, Shi Y, Melino G and Amelio I: p53-mediated tumor suppression: DNA-damage response and alternative mechanisms. Cancers (Basel). 11:19832019. View Article : Google Scholar : PubMed/NCBI
41	Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R and Barlev NA: Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. Cell Death Dis. 12:172021. View Article : Google Scholar : PubMed/NCBI
42	Yang P, Jiang Y, Pan Y, Ding X, Rhea P, Ding J, Hawke DH, Felsher D, Narla G, Lu Z and Lee RT: Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression. Sci Rep. 9:64282019. View Article : Google Scholar : PubMed/NCBI
43	Nakagawa R, Toboso-Navasa A, Schips M, Young G, Bhaw-Rosun L, Llorian-Sopena M, Chakravarty P, Sesay AK, Kassiotis G, Meyer-Hermann M and Calado DP: Permissive selection followed by affinity-based proliferation of GC light zone B cells dictates cell fate and ensures clonal breadth. Proc Natl Acad Sci USA. 118:e20164251182021. View Article : Google Scholar : PubMed/NCBI
44	Kin K, Chen X, Gonzalez-Garay M and Fakhouri WD: The effect of non-coding DNA variations on P53 and cMYC competitive inhibition at cis-overlapping motifs. Hum Mol Genet. 25:1517–1527. 2016. View Article : Google Scholar : PubMed/NCBI
45	Brandner S: Nanog, Gli, and p53: A new network of stemness in development and cancer. EMBO J. 29:2475–2476. 2010. View Article : Google Scholar : PubMed/NCBI
46	Nourian Dehkordi A, Mirahmadi Babaheydari F, Chehelgerdi M and Raeisi Dehkordi S: Skin tissue engineering: Wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 10:1112019. View Article : Google Scholar : PubMed/NCBI
47	Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, Patel SB, Khalid L, Isseroff RR and Tomic-Canic M: Epithelialization in wound healing: A comprehensive review. Adv Wound Care (New Rochelle). 3:445–464. 2014. View Article : Google Scholar : PubMed/NCBI